The Office of Research on Women’s Health (ORWH) recently added over 40 funding opportunity announcements (FOAs) to its website. The studies proposed in these FOAs are specifically relevant to different aspects of women’s health and/or sex and gender research, or the advancement of women in biomedical careers. Several of these new FOAs are listed below:
- Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional)
- Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp – Clinical Trial Not Allowed)
- Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
Deadlines for these FOAs vary. See the individual FOAs for more details.
Information on additional FOAs is available here.